C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-20.74%
↓ 81% below average
Average (26q)
-11.48%
Historical baseline
Range
High:46.10%
Low:-117.08%
Volatility
-1422.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -20.74% |
| Q2 2025 | 2.27% |
| Q1 2025 | 22.66% |
| Q4 2024 | -33.51% |
| Q3 2024 | -31.72% |
| Q2 2024 | 33.45% |
| Q1 2024 | 13.92% |
| Q4 2023 | -34.59% |
| Q3 2023 | 25.98% |
| Q2 2023 | -3.70% |
| Q1 2023 | 5.39% |
| Q4 2022 | -17.87% |
| Q3 2022 | -18.64% |
| Q2 2022 | 12.70% |
| Q1 2022 | -105.63% |
| Q4 2021 | 37.10% |
| Q3 2021 | -9.67% |
| Q2 2021 | 46.10% |
| Q1 2021 | -117.08% |
| Q4 2020 | -3.02% |
| Q3 2020 | -68.98% |
| Q2 2020 | 11.99% |
| Q1 2020 | -17.52% |
| Q4 2019 | -4.98% |
| Q3 2019 | -33.77% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |